Tus-Pharmaceutical Group Co., Ltd.

SZSE:000590 Stock Report

Market Cap: CN¥1.8b

Tus-Pharmaceutical Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Xue Feng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.6yrs
CEO ownershipn/a
Management average tenure4.6yrs
Board average tenure4yrs

Recent management updates

Recent updates

More Unpleasant Surprises Could Be In Store For Tus-Pharmaceutical Group Co., Ltd.'s (SZSE:000590) Shares After Tumbling 25%

Dec 25
More Unpleasant Surprises Could Be In Store For Tus-Pharmaceutical Group Co., Ltd.'s (SZSE:000590) Shares After Tumbling 25%

Tus-Pharmaceutical Group Co., Ltd.'s (SZSE:000590) 37% Price Boost Is Out Of Tune With Revenues

Nov 08
Tus-Pharmaceutical Group Co., Ltd.'s (SZSE:000590) 37% Price Boost Is Out Of Tune With Revenues

Tus-Pharmaceutical Group's (SZSE:000590) Solid Profits Have Weak Fundamentals

Apr 03
Tus-Pharmaceutical Group's (SZSE:000590) Solid Profits Have Weak Fundamentals

Revenues Not Telling The Story For Tus-Pharmaceutical Group Co., Ltd. (SZSE:000590) After Shares Rise 27%

Mar 08
Revenues Not Telling The Story For Tus-Pharmaceutical Group Co., Ltd. (SZSE:000590) After Shares Rise 27%

CEO

Xue Feng (34 yo)

4.6yrs

Tenure

CN¥420,000

Compensation

Mr. Xue Feng serves as the Non Independent Director of Tus-Pharmaceutical Group Co., Ltd. (formerly known as Tus-Guhan Group Corp.,Ltd.) since May 21, 2020 and serves as its President.

Leadership Team

NamePositionTenureCompensationOwnership
Ting Tang
VP, CFO & Non Independent Director8yrsCN¥370.00kno data
Dingxing Cao
VP & Board Secretaryno dataCN¥370.00kno data
Jun Cai
Vice President1.6yrsCN¥345.00kno data
Xue Feng
President & Non Independent Director4.6yrsCN¥420.00kno data

4.6yrs

Average Tenure

44yo

Average Age

Experienced Management: 000590's management team is considered experienced (4.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ting Tang
VP, CFO & Non Independent Director8yrsCN¥370.00kno data
Xue Feng
President & Non Independent Director4.6yrsCN¥420.00kno data
Kebiao Yan
Chairman of the Board of Supervisors7.5yrsno datano data
Qisen Jiao
Chairman of the Board4.2yrsCN¥420.00kno data
Zhengming Huang
Independent Director4yrsCN¥120.00kno data
Jingwei Sun
Supervisor4yrsno datano data
Xiaoqiao Ni
Vice Chairman1.6yrsno datano data
Zhenhua Lei
Independent Director1.6yrsCN¥70.00kno data
Wenbiao Huang
Independent Director1.6yrsno datano data

4.0yrs

Average Tenure

50yo

Average Age

Experienced Board: 000590's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 15:10
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tus-Pharmaceutical Group Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi QuDonghai Securities Co. Ltd.
Yaming LiuFounder Securities Co., Ltd.
Chase DingHSBC